Holen Sie sich die Stockscreener-App
6.28
3.97%
0.23
Schlusskurs vom Vortag:
$6.05
Offen:
$6.16
24-Stunden-Volumen:
141.69K
Relative Volume:
0.13
Marktkapitalisierung:
$65.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.42M
KGV:
-1.1212
EPS:
-5.6013
Netto-Cashflow:
$-7.45M
1W Leistung:
-3.53%
1M Leistung:
-12.88%
6M Leistung:
+163.18%
1J Leistung:
-63.26%
1-Tages-Spanne:
$6.0062
$6.56
1-Wochen-Bereich:
$6.0062
$7.20
52-Wochen-Spanne:
$1.80
$20.63
Cervomed Inc Stock (CRVO) Company Profile
Firmenname
Cervomed Inc
Sektor
Branche
Telefon
(617) 744-4400
Adresse
20 PARK PLAZA, BOSTON
Vergleichen Sie CRVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
6.28 | 65.01M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.33 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
522.20 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.59 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
546.33 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-12-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-18 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-07-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cervomed Inc Aktie (CRVO) Neueste Nachrichten
CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
CervoMed’s (CRVO) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Pric - GuruFocus
CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Price Held Steady | CRVO Stock News - GuruFocus
CervoMed (CRVO) Strengthens Leadership with Key Executive Appoin - GuruFocus
CervoMed (CRVO) Strengthens Leadership with Key Executive Appointment | CRVO Stock News - GuruFocus
CervoMed appoints Marco Verwijs as EVP, technical operations - TipRanks
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization - GlobeNewswire
CervoMed Accelerates Phase 3 DLB Drug Development With Key Manufacturing Expert Hire - Stock Titan
CRVOCervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - mx.advfn.com
Nuveen Asset Management LLC Acquires 22,104 Shares of CervoMed Inc. (NASDAQ:CRVO) - Defense World
BNP Paribas Financial Markets Purchases New Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World
Reviewing CervoMed (CRVO) and Its Peers - Defense World
CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
CervoMed Releases New Business and Financial Information - TipRanks
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
Chardan Capital Raises Earnings Estimates for CervoMed - Defense World
Roth Capital Brokers Reduce Earnings Estimates for CervoMed - Defense World
Brokers Set Expectations for CervoMed Q2 Earnings - Defense World
Insider Buying: William Elder Acquires Additional Shares of Cerv - GuruFocus
CervoMed (NASDAQ:CRVO) Earns “Buy” Rating from D. Boral Capital - Defense World
CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates - MSN
CervoMed’s CFO Makes Bold Move with New Stock Purchase! - TipRanks
CervoMed First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Chardan keeps CervoMed stock Buy rating, $15 target post-results - Investing.com Australia
CervoMed (CRVO) Maintains Buy Rating with Stable Price Target | - GuruFocus
Chardan Adjusts Price Target on CervoMed to $15 From $14, Maintains Buy Rating - marketscreener.com
CervoMed (CRVO) Maintains Buy Rating with Stable Price Target | CRVO Stock News - GuruFocus
CervoMed Announces $50M Sales Agreement with Leerink - TipRanks
Chardan Capital Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World
CervoMed Inc. Reports Q1 2025 Financial Results - TipRanks
Chardan keeps CervoMed stock Buy rating, $15 target post-results By Investing.com - Investing.com South Africa
CervoMed Inc (CRVO) Q1 2025 Earnings: Revenue Beats Estimates at $1.9M, Net Loss Reported - GuruFocus
CervoMed (CRVO): Chardan Capital Raises Price Target | CRVO Stoc - GuruFocus
CervoMed (CRVO): Chardan Capital Raises Price Target | CRVO Stock News - GuruFocus
Cervomed Co Enters Sales Agreement With Leerink Partners LLC - marketscreener.com
CervoMed (CRVO) Financial Position and Funding Outlook | CRVO St - GuruFocus
CervoMed (CRVO) Exceeds Q1 Revenue Expectations Amid Promising T - GuruFocus
CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
SEC Form 10-Q filed by CervoMed Inc. - Quantisnow
CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
CervoMed Inc. Reports Positive Phase 2b Results for Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies and Plans Phase 3 Trial - Nasdaq
CervoMed (CRVO) Financial Position and Funding Outlook | CRVO Stock News - GuruFocus
CervoMed (CRVO) to Release Earnings on Tuesday - Defense World
CervoMed Announces Executive Appointments and Changes - MSN
Mariner LLC Invests $30,000 in CervoMed Inc. (NASDAQ:CRVO) - Defense World
JPMorgan Chase & Co. Grows Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World
CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference - GlobeNewswire
CRVO Shares Experience Surge in Value - knoxdaily.com
Head to Head Comparison: CervoMed (NASDAQ:CRVO) versus Schrödinger (NASDAQ:SDGR) - Defense World
Finanzdaten der Cervomed Inc-Aktie (CRVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cervomed Inc-Aktie (CRVO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ELDER WILLIAM ROBERT | CFO & GC |
Aug 27 '24 |
Buy |
18.16 |
1,000 |
18,160 |
1,267 |
0.39%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):